PCM
LFST icon

Prelude Capital Management’s Lifestance Health LFST Stock Holding History

Prelude Capital Management’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,597
Closed -$158K – 1280
2025
Q2 		$158K Buy
+30,597
New +$183K 0.02% 847
2023
Q3 		– Sell
-10,773
Closed -$98.4K – 1257
2023
Q2 		$98.4K Buy
+10,773
New +$89.5K 0.01% 934

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prelude Capital Management's LFST Position: Q3 2025 in Review

Prelude Capital Management sold out of Lifestance Health (LFST) in Q3 2025, closing a stake of 30,597 shares — an estimated $158K sold.

Prelude Capital Management first reported a position in LFST in Q2 2023 and held it in 2 quarters. The position peaked at $158K in Q2 2025. 210 funds tracked by Wall St. Rank hold LFST as of Q3 2025.

  • Prelude Capital Management reported no remaining Lifestance Health position as of Q3 2025 after selling out during the quarter.
  • Prelude Capital Management sold 30,597 Lifestance Health shares in Q3 2025, an estimated $158K.
  • Prelude Capital Management first reported a position in Lifestance Health in Q2 2023 and held it in 2 quarters.
  • Prelude Capital Management's Lifestance Health position peaked at $158K in Q2 2025.
  • 210 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2025.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.